APO Research

APO RESEARCH · REPORT

Biomedical Testing Services

Selected research

Market Outlook & Growth Opportunities

Global Biomedical Testing Services Market Outlook and Growth Opportunities 2026

Market perspective

The global Biomedical Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biomedical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biomedical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biomedical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biomedical Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biomedical Testing Services market include Electro Medical Analysis, EAG Laboratories, Frontiers, Jordi Labs, Leeder Analytical, EMSL Analytical, Inc., CNA Scientific, USAINS BIOMICS and LA Testing, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biomedical Testing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biomedical Testing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biomedical Testing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biomedical Testing Services market.

Biomedical Testing Services Segment by Company

Electro Medical Analysis

EAG Laboratories

Frontiers

Jordi Labs

Leeder Analytical

EMSL Analytical, Inc.

CNA Scientific

USAINS BIOMICS

LA Testing

Biomedical Testing Services Segment by Type

Surface Analysis

Elemental Analysis

Biomedical Testing Services Segment by Application

Lab

At-line

Biomedical Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biomedical Testing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biomedical Testing Services key companies, revenue, market share, and recent developments.

3. To split the Biomedical Testing Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biomedical Testing Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biomedical Testing Services significant trends, drivers, influence factors in global and regions.

6. To analyze Biomedical Testing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomedical Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomedical Testing Services industry.

Chapter 3: Detailed analysis of Biomedical Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biomedical Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biomedical Testing Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biomedical Testing Services Industry Trends Table 2. Biomedical Testing Services Industry Drivers Table 3. Biomedical Testing Services Industry Opportunities and Challenges Table 4. Biomedical Testing Services Industry Restraints Table 5. Global Biomedical Testing Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biomedical Testing Services Revenue Share by Company (2021-2026) Table 7. Global Biomedical Testing Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biomedical Testing Services Key Company Manufacturing Base & Headquarters Table 9. Global Biomedical Testing Services Company, Product Type & Application Table 10. Global Biomedical Testing Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biomedical Testing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Surface Analysis Table 15. Significant Companies of Elemental Analysis Table 16. Global Biomedical Testing Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Biomedical Testing Services Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Biomedical Testing Services Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Biomedical Testing Services Sales Value Share by Type (2021-2026) Table 20. Global Biomedical Testing Services Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Lab Table 22. Significant Companies of At-line Table 23. Global Biomedical Testing Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Biomedical Testing Services Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Biomedical Testing Services Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Biomedical Testing Services Sales Value Share by Application (2021-2026) Table 27. Global Biomedical Testing Services Sales Value Share by Application (2027-2032) Table 28. Global Biomedical Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Biomedical Testing Services Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Biomedical Testing Services Sales Value Share by Region (2021-2026) Table 31. Global Biomedical Testing Services Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Biomedical Testing Services Sales Value Share by Region (2027-2032) Table 33. Global Biomedical Testing Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Biomedical Testing Services Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Biomedical Testing Services Sales Value Market Share by Country (2021-2026) Table 36. Global Biomedical Testing Services Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Biomedical Testing Services Sales Value Market Share by Country (2027-2032) Table 38. Electro Medical Analysis Company Information Table 39. Electro Medical Analysis Business Overview Table 40. Electro Medical Analysis Biomedical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Electro Medical Analysis Biomedical Testing Services Product Portfolio Table 42. Electro Medical Analysis Recent Development Table 43. EAG Laboratories Company Information Table 44. EAG Laboratories Business Overview Table 45. EAG Laboratories Biomedical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. EAG Laboratories Biomedical Testing Services Product Portfolio Table 47. EAG Laboratories Recent Development Table 48. Frontiers Company Information Table 49. Frontiers Business Overview Table 50. Frontiers Biomedical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Frontiers Biomedical Testing Services Product Portfolio Table 52. Frontiers Recent Development Table 53. Jordi Labs Company Information Table 54. Jordi Labs Business Overview Table 55. Jordi Labs Biomedical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Jordi Labs Biomedical Testing Services Product Portfolio Table 57. Jordi Labs Recent Development Table 58. Leeder Analytical Company Information Table 59. Leeder Analytical Business Overview Table 60. Leeder Analytical Biomedical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Leeder Analytical Biomedical Testing Services Product Portfolio Table 62. Leeder Analytical Recent Development Table 63. EMSL Analytical, Inc. Company Information Table 64. EMSL Analytical, Inc. Business Overview Table 65. EMSL Analytical, Inc. Biomedical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. EMSL Analytical, Inc. Biomedical Testing Services Product Portfolio Table 67. EMSL Analytical, Inc. Recent Development Table 68. CNA Scientific Company Information Table 69. CNA Scientific Business Overview Table 70. CNA Scientific Biomedical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. CNA Scientific Biomedical Testing Services Product Portfolio Table 72. CNA Scientific Recent Development Table 73. USAINS BIOMICS Company Information Table 74. USAINS BIOMICS Business Overview Table 75. USAINS BIOMICS Biomedical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. USAINS BIOMICS Biomedical Testing Services Product Portfolio Table 77. USAINS BIOMICS Recent Development Table 78. LA Testing Company Information Table 79. LA Testing Business Overview Table 80. LA Testing Biomedical Testing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. LA Testing Biomedical Testing Services Product Portfolio Table 82. LA Testing Recent Development Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Biomedical Testing Services Product Image Figure 2. Global Biomedical Testing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biomedical Testing Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Biomedical Testing Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Surface Analysis Image Figure 8. Elemental Analysis Image Figure 9. Global Biomedical Testing Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Biomedical Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Biomedical Testing Services Sales Value Share by Type (2021-2032) Figure 12. Lab Image Figure 13. At-line Image Figure 14. Global Biomedical Testing Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Biomedical Testing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Biomedical Testing Services Sales Value Share by Application (2021-2032) Figure 17. Global Biomedical Testing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Biomedical Testing Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Biomedical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 20. North America Biomedical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Biomedical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Biomedical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Biomedical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Biomedical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Biomedical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 26. South America Biomedical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Biomedical Testing Services Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Biomedical Testing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Biomedical Testing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Surface Analysis
  • Elemental Analysis
Applications
  • Lab
  • At-line
Companies covered
  • Electro Medical Analysis
  • EAG Laboratories
  • Frontiers
  • Jordi Labs
  • Leeder Analytical
  • EMSL Analytical, Inc.
  • CNA Scientific
  • USAINS BIOMICS
  • LA Testing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biomedical Testing Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biomedical Testing Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biomedical Testing Services Market Dynamics
  1. 2.1 Biomedical Testing Services Industry Trends
  2. 2.2 Biomedical Testing Services Industry Drivers
  3. 2.3 Biomedical Testing Services Industry Opportunities and Challenges
  4. 2.4 Biomedical Testing Services Industry Restraints
3 Biomedical Testing Services Market by Company
  1. 3.1 Global Biomedical Testing Services Company Revenue Ranking in 2025
  2. 3.2 Global Biomedical Testing Services Revenue by Company (2021-2026)
  3. 3.3 Global Biomedical Testing Services Company Ranking (2024-2026)
  4. 3.4 Global Biomedical Testing Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Biomedical Testing Services Company Product Type and Application
  6. 3.6 Global Biomedical Testing Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biomedical Testing Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biomedical Testing Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biomedical Testing Services Market by Type
  1. 4.1 Biomedical Testing Services Type Introduction
  2. 4.1.1 Surface Analysis
  3. 4.1.2 Elemental Analysis
  4. 4.2 Global Biomedical Testing Services Sales Value by Type
  5. 4.2.1 Global Biomedical Testing Services Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Biomedical Testing Services Sales Value by Type (2021-2032)
  7. 4.2.3 Global Biomedical Testing Services Sales Value Share by Type (2021-2032)
5 Biomedical Testing Services Market by Application
  1. 5.1 Biomedical Testing Services Application Introduction
  2. 5.1.1 Lab
  3. 5.1.2 At-line
  4. 5.2 Global Biomedical Testing Services Sales Value by Application
  5. 5.2.1 Global Biomedical Testing Services Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Biomedical Testing Services Sales Value by Application (2021-2032)
  7. 5.2.3 Global Biomedical Testing Services Sales Value Share by Application (2021-2032)
6 Biomedical Testing Services Regional Value Analysis
  1. 6.1 Global Biomedical Testing Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biomedical Testing Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biomedical Testing Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biomedical Testing Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biomedical Testing Services Sales Value (2021-2032)
  7. 6.3.2 North America Biomedical Testing Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biomedical Testing Services Sales Value (2021-2032)
  10. 6.4.2 Europe Biomedical Testing Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biomedical Testing Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biomedical Testing Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biomedical Testing Services Sales Value (2021-2032)
  16. 6.6.2 South America Biomedical Testing Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biomedical Testing Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biomedical Testing Services Sales Value Share by Country, 2025 VS 2032
7 Biomedical Testing Services Country-level Value Analysis
  1. 7.1 Global Biomedical Testing Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biomedical Testing Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biomedical Testing Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biomedical Testing Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biomedical Testing Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biomedical Testing Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biomedical Testing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Electro Medical Analysis
  2. 8.1.1 Electro Medical Analysis Company Information
  3. 8.1.2 Electro Medical Analysis Business Overview
  4. 8.1.3 Electro Medical Analysis Biomedical Testing Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Electro Medical Analysis Biomedical Testing Services Product Portfolio
  6. 8.1.5 Electro Medical Analysis Recent Developments
  7. 8.2 EAG Laboratories
  8. 8.2.1 EAG Laboratories Company Information
  9. 8.2.2 EAG Laboratories Business Overview
  10. 8.2.3 EAG Laboratories Biomedical Testing Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 EAG Laboratories Biomedical Testing Services Product Portfolio
  12. 8.2.5 EAG Laboratories Recent Developments
  13. 8.3 Frontiers
  14. 8.3.1 Frontiers Company Information
  15. 8.3.2 Frontiers Business Overview
  16. 8.3.3 Frontiers Biomedical Testing Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Frontiers Biomedical Testing Services Product Portfolio
  18. 8.3.5 Frontiers Recent Developments
  19. 8.4 Jordi Labs
  20. 8.4.1 Jordi Labs Company Information
  21. 8.4.2 Jordi Labs Business Overview
  22. 8.4.3 Jordi Labs Biomedical Testing Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jordi Labs Biomedical Testing Services Product Portfolio
  24. 8.4.5 Jordi Labs Recent Developments
  25. 8.5 Leeder Analytical
  26. 8.5.1 Leeder Analytical Company Information
  27. 8.5.2 Leeder Analytical Business Overview
  28. 8.5.3 Leeder Analytical Biomedical Testing Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Leeder Analytical Biomedical Testing Services Product Portfolio
  30. 8.5.5 Leeder Analytical Recent Developments
  31. 8.6 EMSL Analytical, Inc.
  32. 8.6.1 EMSL Analytical, Inc. Company Information
  33. 8.6.2 EMSL Analytical, Inc. Business Overview
  34. 8.6.3 EMSL Analytical, Inc. Biomedical Testing Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 EMSL Analytical, Inc. Biomedical Testing Services Product Portfolio
  36. 8.6.5 EMSL Analytical, Inc. Recent Developments
  37. 8.7 CNA Scientific
  38. 8.7.1 CNA Scientific Company Information
  39. 8.7.2 CNA Scientific Business Overview
  40. 8.7.3 CNA Scientific Biomedical Testing Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CNA Scientific Biomedical Testing Services Product Portfolio
  42. 8.7.5 CNA Scientific Recent Developments
  43. 8.8 USAINS BIOMICS
  44. 8.8.1 USAINS BIOMICS Company Information
  45. 8.8.2 USAINS BIOMICS Business Overview
  46. 8.8.3 USAINS BIOMICS Biomedical Testing Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 USAINS BIOMICS Biomedical Testing Services Product Portfolio
  48. 8.8.5 USAINS BIOMICS Recent Developments
  49. 8.9 LA Testing
  50. 8.9.1 LA Testing Company Information
  51. 8.9.2 LA Testing Business Overview
  52. 8.9.3 LA Testing Biomedical Testing Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LA Testing Biomedical Testing Services Product Portfolio
  54. 8.9.5 LA Testing Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research